Kymera Therapeutics shares owned by Gilder, Gagnon, Howe & Co
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Gilder, Gagnon, Howe & Co
from 13F filings
Historical chart of Gilder, Gagnon, Howe & Co investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Gilder, Gagnon, Howe & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Gilder, Gagnon, Howe & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $5.3M | 133k | 40.20 |
| 2023-09-30 | $1.1M | 82k | 13.90 |
| 2023-06-30 | $2.0M | 89k | 22.99 |
| 2023-03-31 | $2.7M | 90k | 29.63 |
| 2022-12-31 | $2.3M | 90k | 24.96 |
| 2022-09-30 | $1.8M | 81k | 21.78 |
| 2022-06-30 | $1.9M | 95k | 19.69 |
| 2022-03-31 | $4.8M | 115k | 42.32 |
| 2021-12-31 | $7.6M | 120k | 63.49 |
| 2021-09-30 | $7.7M | 132k | 58.74 |
| 2021-06-30 | $5.3M | 109k | 48.50 |